WebDec 2, 2024 · [email protected]. LHA Investor Relations Tirth T. Patel +1 212 201 6614 [email protected]. Tags

Stock Information – Biofrontera

WebNov 23, 2024 · For more information, visit www.biofrontera-us.com. Contacts. Biofrontera Inc. Pamela Keck +1 781 486 1539 [email protected]. LHA Investor Relations Tirth T. Patel +1 212 201 6614 tpatel@lhai ... WebConnect with us to learn more about Biofrontera Inc., our products and our clinical developments. Biofrontera Inc. 120 Presidential Way, Suite 330 ... Woburn, MA 01801 … to them we owe

Biofrontera is a specialty pharma company in the field of …

WebJohn J. Borer III. John J. Borer III, J.D. became a member of our board of directors in November 2024. Since 2012, he has been the Senior Managing Director and Co-Head of Investment Banking at The Benchmark Company, LLC. He was formerly the Chief Executive Officer and Head of Investment Banking at Rodman & Renshaw, and has held senior … WebCORPORATEOVERVIEW. Biofrontera Inc. (Biofrontera) is a U.S.-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for … Biofrontera is a highly innovative specialty dermatology company, focused on the … Biofrontera is a highly innovative specialty dermatology company, focused on the … Biofrontera Inc. is followed by the research analysts listed below. Please note that … Welcome to Biofrontera Inc. Biofrontera Inc. is a U.S.-based biopharmaceutical … Corporate Governance. Our Board of Directors sets high standards for our … WebNov 2, 2024 · Furthermore, Biofrontera Inc. is strengthening the marketing of its second product Xepi, a topical antibiotic that is approved for the treatment of impetigo, a highly infectious bacterial skin infection, and effective even against antibiotic-resistant bacteria . ... Investor Relations phone: +49 (0) 214 87 63 20 e-mail: [email protected] ... to the museum